BioCentury | May 6, 2020
Management Tracks

Mendel named GenMark’s CEO; plus SutroVax, Illumina, Arrowhead, Tessa and more

GenMark Diagnostics Inc. (NASDAQ:GNMK) said interim president and CEO Scott Mendel will now serve in those roles full-time. He joined the company as CFO in 2014 and became COO in 2019. The diagnostic company’s PCR-based...
BioCentury | Mar 20, 2020
Product Development

Industry continues to build COVID-19 testing capacity

Diagnostics companies are continuing to step up to meet demand for expanded COVID-19 testing capabilities with a range of PCR- and antibody-based tests. PCR-based tests for COVID-19 detect active infection with SARS-CoV-2, while antibody-based tests...
BioCentury | Feb 15, 2020
Management Tracks

Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more

Antibody-drug conjugate company Immunomedics Inc. (NASDAQ:IMMU) hired Loretta Itri as CMO. She was EVP of global health sciences and regulatory affairs at The Medicines Co. (NASDAQ:MDCO). Shanghai-based diabetes company Hua Medicine Ltd. (HKEX:2552) hired Fuxing...
BioCentury | Jan 12, 2019
Finance

JPM jump-starts 2019

About three quarters of the more than 200 biopharma companies presenting at the 2019 J.P. Morgan Healthcare Conference saw their stock prices rise last week. Leading the pack was the 53% jump by Insmed Inc....
BioCentury | Jan 9, 2018
Finance

Stars in China

A major clinical flop and a spate of weak earnings reports by U.S. large cap biotechs reverberated throughout the sector in the fourth quarter, breaking a three-quarter-long streak of outperformance. Across all market cap bands,...
BioCentury | Jul 7, 2017
Finance

Generalists needed

Following a nearly two-year political overhang on the biotech sector, buysiders believe sentiment once again may be turning positive and starting to catch up with the industry’s positive fundamentals. As evidence, they point to the...
BioCentury | Jun 16, 2017
Financial News

GenMark raises $75M in upsized follow-on

On June 13, molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at $11.75 in an upsized follow-on underwritten by JPMorgan, BofA Merrill Lynch, William Blair, Cowen...
BioCentury | Jun 14, 2017
Financial News

GenMark raises $75M in upsized follow-on

Molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at $11.75 in an upsized follow-on underwritten by JPMorgan, BofA Merrill Lynch, William Blair, Cowen and Raymond James....
BioCentury | Apr 26, 2017
Clinical News

ePlex Blood Culture Identification Fungal Pathogen Panel regulatory update

GenMark received CE Mark approval for its ePlex Blood Culture Identification Fungal Pathogen Panel to detect fungal blood stream infections in blood samples. The in vitro diagnostic runs on the company’s ePlex Sepsis Solution platform....
BioCentury | Jun 26, 2015
Company News

Management tracks

Rare disease play Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) hired Gregory Perry as CFO. Perry was CFO at Eleven Biotherapeutics Inc. (NASDAQ:EBIO). Inhalable therapies company Pulmatrix Inc. (NASDAQ:PULM) hired William Duke as CFO. He was CFO at...
Items per page:
1 - 10 of 60
BioCentury | May 6, 2020
Management Tracks

Mendel named GenMark’s CEO; plus SutroVax, Illumina, Arrowhead, Tessa and more

GenMark Diagnostics Inc. (NASDAQ:GNMK) said interim president and CEO Scott Mendel will now serve in those roles full-time. He joined the company as CFO in 2014 and became COO in 2019. The diagnostic company’s PCR-based...
BioCentury | Mar 20, 2020
Product Development

Industry continues to build COVID-19 testing capacity

Diagnostics companies are continuing to step up to meet demand for expanded COVID-19 testing capabilities with a range of PCR- and antibody-based tests. PCR-based tests for COVID-19 detect active infection with SARS-CoV-2, while antibody-based tests...
BioCentury | Feb 15, 2020
Management Tracks

Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more

Antibody-drug conjugate company Immunomedics Inc. (NASDAQ:IMMU) hired Loretta Itri as CMO. She was EVP of global health sciences and regulatory affairs at The Medicines Co. (NASDAQ:MDCO). Shanghai-based diabetes company Hua Medicine Ltd. (HKEX:2552) hired Fuxing...
BioCentury | Jan 12, 2019
Finance

JPM jump-starts 2019

About three quarters of the more than 200 biopharma companies presenting at the 2019 J.P. Morgan Healthcare Conference saw their stock prices rise last week. Leading the pack was the 53% jump by Insmed Inc....
BioCentury | Jan 9, 2018
Finance

Stars in China

A major clinical flop and a spate of weak earnings reports by U.S. large cap biotechs reverberated throughout the sector in the fourth quarter, breaking a three-quarter-long streak of outperformance. Across all market cap bands,...
BioCentury | Jul 7, 2017
Finance

Generalists needed

Following a nearly two-year political overhang on the biotech sector, buysiders believe sentiment once again may be turning positive and starting to catch up with the industry’s positive fundamentals. As evidence, they point to the...
BioCentury | Jun 16, 2017
Financial News

GenMark raises $75M in upsized follow-on

On June 13, molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at $11.75 in an upsized follow-on underwritten by JPMorgan, BofA Merrill Lynch, William Blair, Cowen...
BioCentury | Jun 14, 2017
Financial News

GenMark raises $75M in upsized follow-on

Molecular diagnostics company GenMark Diagnostics Inc. (NASDAQ:GNMK) raised $75 million through the sale of 6.4 million shares at $11.75 in an upsized follow-on underwritten by JPMorgan, BofA Merrill Lynch, William Blair, Cowen and Raymond James....
BioCentury | Apr 26, 2017
Clinical News

ePlex Blood Culture Identification Fungal Pathogen Panel regulatory update

GenMark received CE Mark approval for its ePlex Blood Culture Identification Fungal Pathogen Panel to detect fungal blood stream infections in blood samples. The in vitro diagnostic runs on the company’s ePlex Sepsis Solution platform....
BioCentury | Jun 26, 2015
Company News

Management tracks

Rare disease play Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) hired Gregory Perry as CFO. Perry was CFO at Eleven Biotherapeutics Inc. (NASDAQ:EBIO). Inhalable therapies company Pulmatrix Inc. (NASDAQ:PULM) hired William Duke as CFO. He was CFO at...
Items per page:
1 - 10 of 60